Contrary to popular belief, you can strike it rich on established, high-quality companies. Today, a well-known supercharged growth stock trades at a compelling valuation due to concerns about ...
The market appears to be discounting Medtronic's long-term growth prospects, particularly its neuroscience and diabetes franchises. The stock's price-to-earnings (P/E) ratio has fallen over the ...
Discover why Trip.com Group Limited's Q3 earnings beat expectations, and why there's still room for growth in the Chinese tourism market. Click for my TCOM update.